A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as ...

Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...

A new study by heart researchers at Intermountain Health in Salt Lake City finds that patients with heart disease, ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

A mixed bag of counterintuitive results hinders trial interpretation, but experts still see actionable results.

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

Ten hours or more of sedentary behaviour per day may increase heart failure risk even in those who regularly exercise, a new ...

A new study by heart researchers at Intermountain Health in Salt Lake City finds that patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts of ...

Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...

Consuming a cocoa drink rich in flavanols can mitigate the negative effects of high-fat foods on the vascular system during ...

Lung Cancer and Smoking: What We Really Know The American Cancer Society has already spent more than half a million dollars on its research on lung cancer, and the Board of Directors recently ...